Search

Search Results
Results 1511 - 1518 of 1518 for multiple myeloma
  • White Paper - 14 May 2024
    This article explores the innovative approach of Antibody-Drug Conjugates (ADCs) in cancer therapy, highlighting their targeted delivery of cytotoxic drugs to cancer cells.
  • White Paper - 25 Apr 2023
    While chemotherapy is widely used and quite effective, the side effects are numerous and can be quite severe. Antibody-drug conjugates (ADCs) are a potential cancer therapy that could be both...
  • White Paper - 26 Jul 2022
    In this article, Sino Biological discusses emerging targets that are arising within the field of cancer immunotherapy, They also discuss the importance of cancer as a public health threat.
  • White Paper - 10 Nov 2021
    G-protein coupled receptors (GPCRs) play pivotal roles in signaling pathways and are the most common membrane proteins. Implicated in many diseases, they are an attractive therapeutic target....
  • Supplier - 6 Dec 2012
    Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing.
  • Supplier - 2 Nov 2018
    ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Their mission is to help overcome challenges with innovative tools and solutions from discovery to the...
  • Supplier - 9 Jan 2023
    Transmembrane proteins (TPs) are embedded in the cell membrane and span both the intracellular and extracellular environments.
  • Supplier - 28 Dec 2011
    The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, lab diagnostics, medical IT.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.